Reading the Daily Sentinel letters to the editor, folks just can’t say, “I disagree with the other party…” No, it’s more, “Well, we’ve finally come to be living in a totalitarian dictatorship!” Or, ...

With a market cap of $121,1 billion, Gilead Sciences, Inc. (GILD) is a leading biopharmaceutical company specializing in the discovery, development, and commercialization of innovative medicines.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Gilead Sciences has shored up its antibody-drug conjugate pipeline by licensing a candidate from German biotech Tubulis in a deal worth up to $415 million. The agreement includes an upfront ...

Tucked above depictions of Adam and Eve, the haunting images of Cain and Abel in the Ghent Altarpiece underscore the wages of ...

Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly effective medicine. However, Ben Hargreaves finds that the company’s ...

ABC's Of Kings and Prophets shows exactly what you shouldn't do when dramatizing a biblical story for network TV audiences.

In previous columns, I have shown how certain truths of the faith in the New Testament were prefigured and foreshadowed in the Old Testament. Here, I will focus on the Eucharist. There are a ...

To give a proper perspective on the New Covenant sacrament of reconciliation instituted by Christ, we will explore the Old Testament prefiguration of this sacrament. In the next column ...